Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone
Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy uti...
Saved in:
Published in | Pharmaceutics Vol. 14; no. 5; p. 906 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
21.04.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs. |
---|---|
AbstractList | Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs. Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs.Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs. |
Author | Kim, Hee Young To, Ngoc Bao Lim, Yoongho Cho, Somi Kim Truong, Vi Nguyen-Phuong Ediriweera, Meran Keshawa Nguyen, Yen Thi-Kim |
AuthorAffiliation | 4 Department of Biological Sciences, Konkuk University, Seoul 05029, Korea; yoongho@konkuk.ac.kr 2 Subtropical—Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea; mk.ediriweera@gmail.com 3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00300, Sri Lanka 1 Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea; ntkyen.hcmus@gmail.com (Y.T.-K.N.); tobaongoc.hcmus@gmail.com (N.B.T.); phuongvi.truongnguyen@gmail.com (V.N.-P.T.); hi.khyoung@gmail.com (H.Y.K.) |
AuthorAffiliation_xml | – name: 1 Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea; ntkyen.hcmus@gmail.com (Y.T.-K.N.); tobaongoc.hcmus@gmail.com (N.B.T.); phuongvi.truongnguyen@gmail.com (V.N.-P.T.); hi.khyoung@gmail.com (H.Y.K.) – name: 4 Department of Biological Sciences, Konkuk University, Seoul 05029, Korea; yoongho@konkuk.ac.kr – name: 3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00300, Sri Lanka – name: 2 Subtropical—Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea; mk.ediriweera@gmail.com |
Author_xml | – sequence: 1 givenname: Yen Thi-Kim orcidid: 0000-0001-7111-031X surname: Nguyen fullname: Nguyen, Yen Thi-Kim – sequence: 2 givenname: Ngoc Bao surname: To fullname: To, Ngoc Bao – sequence: 3 givenname: Vi Nguyen-Phuong orcidid: 0000-0002-6099-767X surname: Truong fullname: Truong, Vi Nguyen-Phuong – sequence: 4 givenname: Hee Young surname: Kim fullname: Kim, Hee Young – sequence: 5 givenname: Meran Keshawa orcidid: 0000-0001-9393-9516 surname: Ediriweera fullname: Ediriweera, Meran Keshawa – sequence: 6 givenname: Yoongho surname: Lim fullname: Lim, Yoongho – sequence: 7 givenname: Somi Kim orcidid: 0000-0002-0980-2005 surname: Cho fullname: Cho, Somi Kim |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35631492$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1TAQhiNURC_0EUCW2LAJtWMnjoWEBFEvR2phcWBt2c6k9SGxg-0g9e3x6WlRWyG88WW--T3-x4fFnvMOiuINwR8oFfhkvlFhUgaWZE0kDNdY4OZFcUCEECUTFd17tN4vjmPc4DwoJS0Vr4p9WjeU5NhBsaymWdkwgUvID-h8XIyPgK4gKe1HGyekXI_WyzwHiNF6t6XWCSaXt8g6dNWdlfxk3aGLZVIOfQmgYkKdcgbCHYg6GMeI9C366n36qVJ-yuvi5aDGCMf381Hx4-z0e3dRXn47X3WfL0tT4zqVoNlgKs0M7XnfClxh3VRca0p7aKBnMABT3DCNqQaNgRgmRNsOYqgHbnBPj4rVTrf3aiPnYCcVbqVXVt4d-HAtVcgejiCrdjCi1bhXamCkZZqTFjhTVPSUE8Gy1qed1rzoCXqTHQtqfCL6NOLsjbz2v6UgrMZVmwXe3wsE_2uBmORko8nmKAd-ibJqOKk4r2qR0XfP0I1fgstWbancx0xVmXr7uKK_pTx0NwMfd4AJPsYAgzQ2qZS7mAu0oyRYbr-T_Od3ytn1s-yHC_6f9weEXNSG |
CitedBy_id | crossref_primary_10_1021_acs_jafc_2c07543 crossref_primary_10_3390_ijms231911340 crossref_primary_10_3390_pharmaceutics14091884 crossref_primary_10_1016_j_heliyon_2024_e36226 crossref_primary_10_3389_fphar_2024_1423115 crossref_primary_10_3390_metabo13030345 crossref_primary_10_1007_s12672_024_00978_2 crossref_primary_10_1016_j_abb_2024_110192 crossref_primary_10_3390_cells14010010 crossref_primary_10_1016_j_ijbiomac_2024_139367 |
Cites_doi | 10.1155/2018/5416923 10.1016/j.tibs.2015.12.001 10.1016/j.bioorg.2020.104294 10.1016/j.stemcr.2019.08.015 10.1038/emm.2016.16 10.1016/j.chembiol.2014.05.014 10.1093/gbe/evt129 10.1111/j.1432-1033.1995.tb20498.x 10.18632/oncotarget.3629 10.1007/s00253-009-1968-x 10.1126/science.1112014 10.1016/j.cmet.2017.10.009 10.1016/j.phymed.2019.153000 10.1038/s41598-017-14364-2 10.1042/BJ20141142 10.1016/j.trecan.2017.08.007 10.5483/BMBRep.2018.51.7.112 10.1016/j.cell.2006.01.016 10.1158/1535-7163.MCT-15-0621 10.4161/cbt.9.12.12347 10.1016/j.ajpath.2011.03.005 10.1038/cddis.2014.285 10.1186/s12943-016-0555-x 10.1007/978-1-4939-8876-1_10 10.1126/science.1215327 10.1038/nrm.2017.95 10.3390/nu10121829 10.1016/S2214-109X(20)30215-1 10.1371/journal.pone.0053372 10.1016/j.biocel.2012.08.022 10.1073/pnas.0530291100 10.1002/jcp.22264 10.1186/s13058-016-0712-6 10.1016/j.ccr.2013.01.022 10.1007/s00441-007-0466-7 10.1016/j.febslet.2008.06.044 10.1093/protein/8.2.127 10.1038/onc.2009.252 10.1186/s12885-020-07379-y 10.1371/journal.pone.0122889 10.1200/JCO.2007.15.1829 10.3390/ijms18122574 10.1002/9781118670613 10.1006/meth.2001.1262 10.3390/nu12061663 10.1369/jhc.2010.955773 10.1016/S0092-8674(03)00929-2 10.3892/or.2021.7924 10.3389/fgene.2019.01119 10.1126/science.1160809 10.1016/j.bmc.2017.07.062 10.1152/ajpendo.00774.2009 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION NPM 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/pharmaceutics14050906 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central (New) ProQuest One Community College ProQuest Central Korea ProQuest Central Student ProQuest Research Library ProQuest Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central (New) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1999-4923 |
ExternalDocumentID | oai_doaj_org_article_28fc98b0daaf4184b718e74a39d37194 PMC9145028 35631492 10_3390_pharmaceutics14050906 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: 2020R1A2C1004349 – fundername: Ministry of Education grantid: 2016R1A6A1A03012862 |
GroupedDBID | --- 53G 5VS 8G5 AADQD AAYXX ABDBF ABUWG ACGFO ACIHN ACUHS AEAQA AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AZQEC BENPR BPHCQ CCPQU CITATION DIK DWQXO EBD ESX F5P FD6 GNUQQ GROUPED_DOAJ GUQSH GX1 HH5 HYE IAO IHR ITC KQ8 M2O M48 MK0 MODMG M~E OK1 P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TR2 TUS 3V. NPM 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c505t-eb4fc2b4c3d7d89020b627bb33de6ed4efe4a7c4b03beb0e1c49988f9f5f7c0d3 |
IEDL.DBID | M48 |
ISSN | 1999-4923 |
IngestDate | Wed Aug 27 01:31:45 EDT 2025 Thu Aug 21 13:59:26 EDT 2025 Fri Jul 11 05:03:19 EDT 2025 Mon Jun 30 07:29:10 EDT 2025 Thu Jan 02 22:54:28 EST 2025 Tue Jul 01 03:36:12 EDT 2025 Thu Apr 24 23:04:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | cancer metabolism AMPK breast cancer stem cells nootkatone oxidative phosphorylation glycolysis |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c505t-eb4fc2b4c3d7d89020b627bb33de6ed4efe4a7c4b03beb0e1c49988f9f5f7c0d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0002-0980-2005 0000-0002-6099-767X 0000-0001-7111-031X 0000-0001-9393-9516 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/pharmaceutics14050906 |
PMID | 35631492 |
PQID | 2670337252 |
PQPubID | 2032349 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_28fc98b0daaf4184b718e74a39d37194 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9145028 proquest_miscellaneous_2671277259 proquest_journals_2670337252 pubmed_primary_35631492 crossref_citationtrail_10_3390_pharmaceutics14050906 crossref_primary_10_3390_pharmaceutics14050906 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20220421 |
PublicationDateYYYYMMDD | 2022-04-21 |
PublicationDate_xml | – month: 4 year: 2022 text: 20220421 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Pharmaceutics |
PublicationTitleAlternate | Pharmaceutics |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Eyler (ref_34) 2008; 26 Inoki (ref_15) 2003; 115 Lin (ref_38) 2010; 9 Dong (ref_8) 2013; 23 Wullschleger (ref_13) 2006; 124 Guo (ref_54) 2020; 104 Liberti (ref_6) 2016; 41 Livak (ref_23) 2001; 25 Tan (ref_31) 2016; 15 Murase (ref_18) 2010; 299 Cantley (ref_5) 2009; 324 ref_21 Wicha (ref_51) 2003; 100 ref_20 Marchitti (ref_42) 2010; 58 Kim (ref_43) 2016; 48 Storci (ref_39) 2010; 225 Mori (ref_41) 2019; 13 ref_26 Corton (ref_44) 1995; 229 Heer (ref_1) 2020; 8 Hawley (ref_45) 2012; 336 Moon (ref_22) 2021; 45 Pestell (ref_7) 2016; 18 Chae (ref_10) 2018; 51 Keng (ref_4) 2011; 9 Soeda (ref_9) 2009; 28 ref_33 Kim (ref_24) 2017; 25 ref_30 Yu (ref_35) 2012; 44 Zhang (ref_32) 2013; 5 Eketunde (ref_53) 2020; 12 Moreno (ref_46) 2008; 582 Lin (ref_16) 2018; 27 Jensen (ref_48) 2015; 467 Deshmukh (ref_11) 2016; 15 Hung (ref_19) 2019; 63 Herzig (ref_14) 2018; 19 Li (ref_50) 2017; 7 Carninci (ref_37) 2005; 309 Li (ref_12) 2015; 6 Phi (ref_27) 2018; 2018 ref_3 Ciavardelli (ref_28) 2014; 5 ref_2 Popov (ref_52) 2011; 179 Ramos (ref_49) 2017; 3 Li (ref_36) 2019; 10 Wallace (ref_25) 1995; 8 Aigner (ref_40) 2008; 331 Vangapandu (ref_29) 2019; 1881 Hunter (ref_47) 2014; 21 Fraatz (ref_17) 2009; 83 |
References_xml | – volume: 2018 start-page: 5416923 year: 2018 ident: ref_27 article-title: Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment publication-title: Stem Cells Int. doi: 10.1155/2018/5416923 – volume: 41 start-page: 211 year: 2016 ident: ref_6 article-title: The Warburg Effect: How Does it Benefit Cancer Cells? publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2015.12.001 – volume: 104 start-page: 104294 year: 2020 ident: ref_54 article-title: Discovery, biological evaluation and docking studies of novel N-acyl-2-aminothiazoles fused (+)-nootkatone from Citrus paradisi Macf. as potential α-glucosidase inhibitors publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2020.104294 – volume: 13 start-page: 730 year: 2019 ident: ref_41 article-title: ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2019.08.015 – volume: 48 start-page: e224 year: 2016 ident: ref_43 article-title: AMPK activators: Mechanisms of action and physiological activities publication-title: Exp. Mol. Med. doi: 10.1038/emm.2016.16 – volume: 21 start-page: 866 year: 2014 ident: ref_47 article-title: Mechanism of action of compound-13: An α1-selective small molecule activator of AMPK publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2014.05.014 – volume: 5 start-page: 1781 year: 2013 ident: ref_32 article-title: Mitochondrial-nuclear interactions: Compensatory evolution or variable functional constraint among vertebrate oxidative phosphorylation genes? publication-title: Genome Biol. Evol. doi: 10.1093/gbe/evt129 – volume: 229 start-page: 558 year: 1995 ident: ref_44 article-title: 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1995.tb20498.x – volume: 6 start-page: 7365 year: 2015 ident: ref_12 article-title: Targeting AMPK for cancer prevention and treatment publication-title: Oncotarget doi: 10.18632/oncotarget.3629 – volume: 83 start-page: 35 year: 2009 ident: ref_17 article-title: Nootkatone—A biotechnological challenge publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s00253-009-1968-x – volume: 309 start-page: 1559 year: 2005 ident: ref_37 article-title: The transcriptional landscape of the mammalian genome publication-title: Science doi: 10.1126/science.1112014 – volume: 27 start-page: 299 year: 2018 ident: ref_16 article-title: AMPK: Sensing Glucose as well as Cellular Energy Status publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.10.009 – volume: 63 start-page: 153000 year: 2019 ident: ref_19 article-title: Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin publication-title: Phytomedicine doi: 10.1016/j.phymed.2019.153000 – volume: 7 start-page: 13856 year: 2017 ident: ref_50 article-title: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis publication-title: Sci. Rep. doi: 10.1038/s41598-017-14364-2 – volume: 467 start-page: 461 year: 2015 ident: ref_48 article-title: PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain publication-title: Biochem. J. doi: 10.1042/BJ20141142 – volume: 3 start-page: 780 year: 2017 ident: ref_49 article-title: New Opportunities and Challenges to Defeat Cancer Stem Cells publication-title: Trends Cancer doi: 10.1016/j.trecan.2017.08.007 – volume: 51 start-page: 319 year: 2018 ident: ref_10 article-title: Cancer stem cell metabolism: Target for cancer therapy publication-title: BMB Rep. doi: 10.5483/BMBRep.2018.51.7.112 – volume: 124 start-page: 471 year: 2006 ident: ref_13 article-title: TOR signaling in growth and metabolism publication-title: Cell doi: 10.1016/j.cell.2006.01.016 – volume: 15 start-page: 774 year: 2016 ident: ref_31 article-title: The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-15-0621 – volume: 9 start-page: 949 year: 2010 ident: ref_38 article-title: Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.9.12.12347 – volume: 179 start-page: 2 year: 2011 ident: ref_52 article-title: The role of breast cancer stem cells in metastasis and therapeutic implications publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2011.03.005 – volume: 5 start-page: e1336 year: 2014 ident: ref_28 article-title: Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.285 – volume: 15 start-page: 69 year: 2016 ident: ref_11 article-title: Cancer stem cell metabolism: A potential target for cancer therapy publication-title: Mol. Cancer doi: 10.1186/s12943-016-0555-x – volume: 1881 start-page: 121 year: 2019 ident: ref_29 article-title: Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-8876-1_10 – volume: 336 start-page: 918 year: 2012 ident: ref_45 article-title: The ancient drug salicylate directly activates AMP-activated protein kinase publication-title: Science doi: 10.1126/science.1215327 – volume: 19 start-page: 121 year: 2018 ident: ref_14 article-title: AMPK: Guardian of metabolism and mitochondrial homeostasis publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm.2017.95 – ident: ref_21 doi: 10.3390/nu10121829 – volume: 8 start-page: e1027 year: 2020 ident: ref_1 article-title: Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(20)30215-1 – ident: ref_26 doi: 10.1371/journal.pone.0053372 – volume: 44 start-page: 2144 year: 2012 ident: ref_35 article-title: Cancer stem cells publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2012.08.022 – volume: 100 start-page: 3983 year: 2003 ident: ref_51 article-title: Prospective identification of tumorigenic breast cancer cells publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0530291100 – volume: 225 start-page: 682 year: 2010 ident: ref_39 article-title: TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype publication-title: J. Cell. Physiol. doi: 10.1002/jcp.22264 – volume: 18 start-page: 55 year: 2016 ident: ref_7 article-title: Cancer stem cell metabolism publication-title: Breast Cancer Res. doi: 10.1186/s13058-016-0712-6 – volume: 23 start-page: 316 year: 2013 ident: ref_8 article-title: Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.01.022 – volume: 331 start-page: 225 year: 2008 ident: ref_40 article-title: TGF-beta in neural stem cells and in tumors of the central nervous system publication-title: Cell Tissue Res. doi: 10.1007/s00441-007-0466-7 – volume: 12 start-page: e8010 year: 2020 ident: ref_53 article-title: Diabetes as a Risk Factor for Breast Cancer publication-title: Cureus – volume: 582 start-page: 2650 year: 2008 ident: ref_46 article-title: A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism publication-title: FEBS Lett. doi: 10.1016/j.febslet.2008.06.044 – volume: 8 start-page: 127 year: 1995 ident: ref_25 article-title: LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions publication-title: Protein Eng. doi: 10.1093/protein/8.2.127 – volume: 28 start-page: 3949 year: 2009 ident: ref_9 article-title: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha publication-title: Oncogene doi: 10.1038/onc.2009.252 – ident: ref_20 doi: 10.1186/s12885-020-07379-y – ident: ref_30 doi: 10.1371/journal.pone.0122889 – volume: 26 start-page: 2839 year: 2008 ident: ref_34 article-title: Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2007.15.1829 – ident: ref_2 doi: 10.3390/ijms18122574 – ident: ref_33 doi: 10.1002/9781118670613 – volume: 25 start-page: 402 year: 2001 ident: ref_23 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method publication-title: Methods doi: 10.1006/meth.2001.1262 – ident: ref_3 doi: 10.3390/nu12061663 – volume: 58 start-page: 765 year: 2010 ident: ref_42 article-title: Aldehyde dehydrogenase 3B1 (ALDH3B1): Immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues publication-title: J. Histochem. Cytochem. doi: 10.1369/jhc.2010.955773 – volume: 115 start-page: 577 year: 2003 ident: ref_15 article-title: TSC2 mediates cellular energy response to control cell growth and survival publication-title: Cell doi: 10.1016/S0092-8674(03)00929-2 – volume: 45 start-page: 1133 year: 2021 ident: ref_22 article-title: Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells publication-title: Oncol. Rep. doi: 10.3892/or.2021.7924 – volume: 10 start-page: 1119 year: 2019 ident: ref_36 article-title: Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated with Prognosis publication-title: Front. Genet. doi: 10.3389/fgene.2019.01119 – volume: 324 start-page: 1029 year: 2009 ident: ref_5 article-title: Understanding the Warburg effect: The metabolic requirements of cell proliferation publication-title: Science doi: 10.1126/science.1160809 – volume: 25 start-page: 5423 year: 2017 ident: ref_24 article-title: Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2017.07.062 – volume: 299 start-page: E266 year: 2010 ident: ref_18 article-title: Nootkatone, a characteristic constituent of grapefruit, stimulates energy metabolism and prevents diet-induced obesity by activating AMPK publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00774.2009 – volume: 9 start-page: 13 year: 2011 ident: ref_4 article-title: Isolation and comparison of tumorigenicity of different cell populations from the MCF-7 breast cancer cell line based on CD44 and CD24 markers publication-title: Vietnam J. Biotechnol. |
SSID | ssj0000331839 |
Score | 2.3144002 |
Snippet | Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 906 |
SubjectTerms | AMPK Breast cancer breast cancer stem cells cancer metabolism Cancer therapies Cell culture Chemotherapy Energy Glucose glycolysis Kinases Metabolism nootkatone oxidative phosphorylation Population Radiation therapy Software Stem cells Tumors |
SummonAdditionalLinks | – databaseName: DOAJ (Directory of Open Access Journals) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ja9wwFBYlp15K906bBhVKTnFHlmTLPiam07QwIZAEcjNaycDEE8aew_z7vmc5s5RALr3akq3lbZ_0FkK-a62CTZlLgi4AoDhgKRMCSzCqsxRep6a_0Z1e5Oc38s9tdrtT6gt9wmJ64LhwY14EWxaGOa2DBDhiQJh6JbUonVCAwFH6gs7bAVO9DBZIq2UM2RGA68cPd9sj4hZQBShKrHK0o4z6nP1PGZr_-kvuKKDJa_JqsBzpaRzxG_LCN2_J8WX84fqEXm8jqdoTekwvt0mp1-_I6jfw_WyJZ4F0Eeiv6KlOp74DKpjP2nuqG0exxmd0jG2w1VXn71EU0llDp9UkUeOrivbH_vQMndk7WiHRLPuGtPLzeUvNml4sFh3GJTX-PbmZ_LyuzpOh5EJiwRTqEm9ksNxIK5xyeAXJTM6VMUI4n3snffBSKysNE8Yb5lMLiKkoQhmyoCxz4gM5aODznwgNDEwvl-ZKaxAUMhSF5waMmUJpDjqRj4h8XPvaDvnIsSzGvAZcgltWP7llI_Jj0-0hJuR4rsMZbuymMebT7h8AldUDldXPUdmIHD6SRT0weVvzHMSlUDyDuXzbvAb2xDsX3fjFqm-TckAwWTkiHyMVbUYislwAQIXeao--9oa6_6aZ3fUpwMtUZmAZfv4fc_tCXnKM6WAy4ekhOeiWK_8VLK3OHPVM9Rc_ISr8 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central (New) dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3Nb9MwFLdgu3BBjM_AQEZCOy00sZ04OSFarQykVhXbpN0iO7a3Sl1SmvTQ_37vJWm6ogmusZ1Y8fv6Pb8PQr4oJV0eBsZ3KgGAYoCltHOBj1mdKbcq1M2N7mQan1-JX9fRdedwq7qwyq1MbAS1KXP0kQ9YDLTJJYvYt-UfH7tG4e1q10LjKTkEEZwA-Docnk1nv3svCyxBE6BN3eGA7wfL252ruAJ0AQoTux09UEpN7f7HDM6_4yYfKKLxC_K8syDp9_bIj8gTW7wkJ7P2g5tTernLqKpO6Qmd7YpTb16R9U_g__kKfYK0dPRHG7FOJ7YGaljMqzuqCkOx12cbIFvgrIva3qFIpPOCTkZjXw4uRrRx_9MhBrXXdITEs2om0pFdLCqqN3RaljXmJxX2Nbkan12Ozv2u9YKfg0lU-1YLlzMtcm6kwavIQMdMas25sbE1wjorlMyFDri2OrBhDsgpSVzqIifzwPA35KCA178j1AVggpkwlkqBwBAuSSzTYNQkUjHQjcwjYvvvs7yrS47tMRYZ4BM8suzRI_PI137Zsi3M8b8FQzzYfjLW1W4elKubrGPTjCUuTxMdGKWcAPCrQXVbKRRPDZdhKjxyvCWLrGP2KtuRpkc-98PApnj3ogpbrps5IQMkE6UeedtSUb8THsUcgCqslnv0tbfV_ZFiftuUAk9DEYGF-P7f2_pAnjHM2giEz8JjclCv1vYj2FK1_tQxzD2dBiQH priority: 102 providerName: ProQuest |
Title | Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35631492 https://www.proquest.com/docview/2670337252 https://www.proquest.com/docview/2671277259 https://pubmed.ncbi.nlm.nih.gov/PMC9145028 https://doaj.org/article/28fc98b0daaf4184b718e74a39d37194 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELem7YUXxDeFURkJ7WnZEtuJkweEaLUykFpVbJX2FtmxvVXK0tGmEv3vuXPSlqIixGv8kcS-r5_Pd0fIB6WkK6LQBE6lAFAMsJR2LgwwqjPjVkXae3SHo-RyIr7dxDcHZJ1QoV3AxV5oh_WkJvPy7OeP1Sdg-I-IOAGynz_cbU9_FwAYQAdiEu4jUE4SeXXYWvxeOHMk4sz7mjOsr8Z4E9fz95l2NJZP7L_PGv3zUuVvWmrwhDxuzUv6uaGHp-TAVs_Iybh54eqUXm_DrRan9ISOt5mrV8_J8isIh-kcDwzpzNEvzXV2OrQ1kEo5XdxTVRmKhUCb27MV9rqq7T3KSzqt6LA_COT5VZ963wDt4Y33mvaRsua-I-3bslxQvaKj2azG4KXKviCTwcV1_zJo6zIEBdhLdWC1cAXTouBGGvRThjphUmvOjU2sEdZZoWQhdMi11aGNCoBVaeoyFztZhIa_JIcVTP-aUBeCfWaiRCoF0kS4NLVMg8WTSsVAcbIOEeu1z4s2aTnWzihzAC-4ZfneLeuQs82whyZrx78G9HBjN50x6bZ_MJvf5i0P5yx1RZbq0CjlBCBjDXrdSqF4ZriMMtEhx2uyyNeEnLMEZCqXLIZ_eb9pBh5Gx4yq7Gzp-0QMYE6cdcirhoo2X8LjhAOKhdFyh752PnW3pZre-TzhWSRiMB_f_O9ivCWPGAZ5hCJg0TE5rOdL-w5Mr1p3yVHvYjT-3vVHF13PWr8Alpkz_g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLdGd4ALGt9lA4wEOy00sZ04OSBEy0rL1qpinbRbZsc2q9QlpUmF-k_xN_KcpO2KJjjtGtuJlff83vv5fSH0TghuEs9VjhEhABQFR0oa4zo2qzOiWniy9OgOhkHvnH278C920O9VLowNq1zJxFJQqyyxd-QtEgBvUk588mn207Fdo6x3ddVCo2KLE738BZAt_9j_AvR9T0j3eNzpOXVXAScBbV84WjKTEMkSqriyXjZXBoRLSanSgVZMG80ET5h0qdTS1V4CoCAMTWR8wxNXUXjvPbTLKECZBtptHw9H39e3OrBFa3JUqUKURm5rdrW5ms4BzYCCtt2VbijBslfAbQbu33GaNxRfdw89rC1W_LlisUdoR6eP0eGo-uDyCI83GVz5ET7Eo00x7OUTtOiDvJnM7R0kzgz-WkXI44EugPumk_wai1Rh21u0CshN7ayzQl9bEYwnKR50ug5vnXVw6W7AbRtEX-COZdZ5ORF39HSaY7nEwywrbD5Uqp-i8zshyjPUSOH1LxA2Lph8ygu4ECCgmAlDTSQYUSEXBHQxaSK2-vdxUtdBt-04pjHgIUuy-FaSNdGH9bJZVQjkfwvalrDrybaOd_kgm_-Ia7EQk9AkUShdJYRhALYlmAqaM0EjRbkXsSY6WLFFXAuXPN4chSZ6ux4GsWB9PSLV2aKc4xFATn7URM8rLlrvhPoBBWAMq_kWf21tdXsknVyVpccjj_lgkb7897beoPu98eA0Pu0PT_bRA2IzRlzmEO8ANYr5Qr8CO66Qr-vDg9HlXZ_XP2nWY04 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEHcKA4wEe1qoYztx8oAQ7VZWxqqKbdLeMju2WaUuKU0q1L_Gr-M4SdsVTfC018ZOrZzr53ND6J2UwqY-0Z6VEQAUDSKlrCWeq-qMmZG-qiK6x8Pw8Ix_PQ_Ot9DvZS2MS6tc6sRKUes8dXfkHRoCbzJBA9qxTVrEaL__afrTcxOkXKR1OU6jZpEjs_gF8K34ONgHWr-ntH9w2jv0mgkDXgqWv_SM4jaliqdMC-0ibkSFVCjFmDah0dxYw6VIuSJMGUWMnwJAiCIb28CKlGgG772DtgWgItJC292D4ej76oYHjuvcj7psiLGYdKaX62vqApANGGs3aemaQazmBtzk7P6ds3nNCPYfoPuN94o_1-z2EG2Z7BHaHdV_uNjDp-tqrmIP7-LRujH24jGaD0D3jGfuPhLnFn-ps-XxsSmBEyfj4grLTGM3Z7ROzs3cqpPSXDl1jMcZPu71PdE56eEq9IC7LqG-xD3HuLNqIe6ZyaTAaoGHeV662qjMPEFnt0KUp6iVweufI2wJuH_aD4WUoKy4jSJDFThUkZAU7DJtI7789kna9ER3ozkmCWAjR7LkRpK10YfVtmndFOR_G7qOsKvFrqd39UM--5E0KiKhkU3jSBEtpeUAvBW4DUZwyWLNhB_zNtpZskXSKJoiWYtFG71dPQYV4eI-MjP5vFrjU0BRQdxGz2ouWp2EBSEDkAy7xQZ_bRx180k2vqzakMc-D8A7ffHvY71Bd0FOk2-D4dFLdI-64hHCPervoFY5m5tX4NKV6nUjOxhd3La4_gGRYGeD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impairment+of+Glucose+Metabolism+and+Suppression+of+Stemness+in+MCF-7%2FSC+Human+Breast+Cancer+Stem+Cells+by+Nootkatone&rft.jtitle=Pharmaceutics&rft.au=Nguyen%2C+Yen+Thi-Kim&rft.au=To%2C+Ngoc+Bao&rft.au=Truong%2C+Vi+Nguyen-Phuong&rft.au=Kim%2C+Hee+Young&rft.date=2022-04-21&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=5&rft.spage=906&rft_id=info:doi/10.3390%2Fpharmaceutics14050906&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_pharmaceutics14050906 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon |